Home
Department of Clinical Science

News archive for Department of Clinical Science

As many as 50 per cent of women suffering from cardiac arrest are given insufficient treatment, because the heart failure was not caused by a heart attack.
As a child, Silke Appel was taken on ski trips to Geilo with her family from Berlin. Today she is a research director and deputy head of the Broegelmann Research Laboratory in Bergen, thanks to financial support from the Trond Mohn Foundation.
Researchers at the University of Bergen have identified new genetic signals for the regulation of how infants grow. This may be a crucial step in the fight against growth-related diseases.
In December 2018, professor Per Eystein lønning and senior researcher Stian Knappskog each received a new research grant of 10 mill NOK from the Norwegian Research Council under the FRIMEDBIO program. Since only 5-10% of all applications to this program are funded, we are very happy that two groups within our research environment received such grants.
You don’t only avoid holes in your teeth by keeping good oral hygiene, researchers at the University of Bergen have discovered a clear connection between gum disease and Alzheimer´s disease.
For the first time, researchers have shown that ordinary human cells can change their original function. The UiB-resarch published in Nature may give new hope for diabetes patients.
Researchers have found that neighbour-cells can take over functions of damaged or missing insulin-producing cells. The discovery may lead to new treatments for diabetes
In December 2018, professor Per Eystein lønning and senior researcher Stian Knappskog each received a new research grant of 10 mill NOK from the Norwegian Research Council under the FRIMEDBIO program. Since only 5-10% of all applications to this program are funded, we are very happy that two groups within our research environment received such grants.
Major milestone for our studies in the Norwegian Mother and Child Cohort study (MoBa). Preprint describing the first GWAS to emerge from an ongoing  nationwide initiative to create a genotype resource for the entire Norwegian Mother and Child Cohort Study, capitalizing on a wealth of phenotypic data from 114,000 children.
New prototype launched at Ultradian consortium meeting
The Ultradian project is now on Twitter.
The Ultradian Platform for Metabolomics at the University of Bergen has completed the development of the 3rd Generation Steroid Hormone Assay.
Professor C. Ronald Kahn from Joslin Diabetes Center, Harvard Medical School is a world recognized expert in diabetes and obesity research, as well as a preeminent investigator in the area of insulin signal transduction and mechanisms of altered signaling in diabetes and metabolic disease. Prof. Kahn has received more than 70 awards and honors, including the highest honors of the American... Read more
Marie Holm Solheim held her Public defence April 19th 2018 for PhD degree at the University of Bergen with titel: "PI 3-kinase regulation of mice and men: Novel aspects of insulin and growth factor signaling".

Pages